Vaccine safety

RETRACTED: Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children

Wakefield AJ, Murch SH, Anthony A, Linnell J, Casson DM, Malik M, et al. Lancet. 1998 Feb 28.

RETRACTED: We investigated a consecutive series of children with chronic enterocolitis and regressive developmental disorder.

Link to full text

Target: 
Healthcare Professionals
Topic: 
Vaccination
Tags: 
Vaccine, Autism, Vaccine safety, Andrew Wakefield

Vaccine Safety: Examine the Evidence

American Academy of Pediatrics. 2013 April. Vaccine Safety: Examine the Evidence.

The safety an​d effectiveness of vaccines​ are under constant study. ​Over the past decade, questions have been raised regarding a relationship between autism and vaccines. Along with general safety concerns, parents have wondered about:

Target: 
Healthcare Professionals
Topic: 
Vaccination
Tags: 
American Academy of Pediatrics, Vaccines, Vaccine safety

The winners for the ASSET best practice award

Thursday, February 23, 2017 - 16:30

The second edition of the ASSET best practice award for general practitioners has come to an end, with the assignment of the four grants to health professionals or groups of health professionals working in the primary health sector.

Target: 
Healthcare Professionals
Topic: 
Gender, Human Rights, Local Activities, Prevention, Stakeholders, Vaccination
Tags: 
gender issues, Vaccine, Vaccine hesitancy, Vaccine safety, Roma, Pregnancy

Towards an extension of mandatory vaccination in Italy?

Monday, February 6, 2017 - 10:44

Immunization rates in Italy are decreasing at a worrying trend: international targets for measles eradication and safety thresholds in childhood vaccination are vanishing. Authorities, doctors and families are concerned that a coverage below 86% for MPR (measles, parotitis and rubella) vaccine can impair herd immunity, putting younger babies, immunocompromised people and not-responders at risk.

Target: 
Citizens, Government and Public Health, Healthcare Professionals, School and Education
Topic: 
Prevention, Stakeholders, Vaccination
Tags: 
Vaccine, Vaccine hesitancy, Vaccine safety, communication, engagement, public health

Flu Effect on the web: an Italian analysis on influenza and vaccination

Thursday, December 29, 2016 - 09:01

The internet deals a lot with flu, but mostly talks about care and little about prevention. This is the result of a study made by Voices from the Blogs, a spin-off of the University of Milan, on the web-sentiment on influenza and vaccination in Italy.

Target: 
Citizens, School and Education
Topic: 
Prevention, Social Media, Vaccination
Tags: 
flu, influenza, Vaccine, Vaccine safety, Social media

Changing the citizen behaviour to improve public health and increase vaccination awareness – Carta Italiana

A very recent and innovative example of good practice concerning awareness campaigns is the “Italian Chart for the Promotion of Vaccinations”, a recent call for action whose website is: http://www.teamvaxitalia.it/. Namely, the Chart is the result of the efforts of the “TeamVaxItaly” movement that had been founded in a civil society meeting in Fano (Italy) in October 2015.

Country: 
Italy
Target: 
Citizens, Decision Makers, Government and Public Health, Healthcare Professionals
Topic: 
Human Rights, Local Activities, Stakeholders, Vaccination
Tags: 
Vaccine, Vaccine hesitancy, Vaccine safety, best practice

Epidemic preparedness and response: Europe listens to the citizens’ voice

Friday, September 23, 2016 - 12:21

One day, eight countries, fifty participants for each of them, open discussions and a series of questions. These are the ingredients of the citizen consultations organized by ASSET on September 24th, to voice people’s opinion on epidemic preparedness and response.

Target: 
Citizens, Decision Makers, Government and Public Health, Healthcare Professionals, School and Education
Topic: 
Citizens' Mobilization, Local Activities, Mutual Learning, Policy, Prevention, Stakeholders, Vaccination
Tags: 
citizen consultation, Vaccine, Vaccine safety, science-in-society

Vaccines: a case history of false balance on TV

Monday, May 23, 2016 - 11:09

Until the end, it seemed it could sort out to be a happy-ending story, a demonstration of how new social networks, renown for spreading misinformation, can also correct it, when used properly. But the unfortunately predictable finale showed the opposite: counteracting false ideas about vaccines is not that easy. It will take time, a big deal of patience, communication skills and a good, coordinated strategy as well.

Target: 
Citizens, Decision Makers, Government and Public Health, Healthcare Professionals, Industry & Commerce, School and Education
Topic: 
Media, Social Media, Stakeholders, Vaccination
Tags: 
Vaccine, Vaccine hesitancy, Vaccine safety, Social media, false balance

Cooperation and engagement for a polio-free world

Friday, May 6, 2016 - 11:11

“We are so close to ending the polio” and “Still 15 years to a polio-free world” are not contradictory statements. They instead describe, with different degree of optimism, the current framework and the objective to be pursued in the fight against this disease. In other words, we are closer than ever to the target of a world free of polio, but much remains to be done to carry the world across the threshold. Polio eradication is the next issue public health authorities will be committed to in midterm future.

Target: 
Citizens, Decision Makers, Government and Public Health, Healthcare Professionals, Industry & Commerce, School and Education
Topic: 
Epidemiology, Media, Microbiology, Prevention, Stakeholders, Vaccination
Tags: 
polio, Vaccine, Vaccine safety, Surveillance, engagement, ECDC

Vaccination in pregnancy: safe and effective

April 26, 2016

As it was proved during 2009 A(H1N1) pandemic, vaccinating pregnant women against flu is usually safe and can protect both mother and children. Vaccination against whooping cough is recommended as well, while vaccines with live virus, such as nasal spray flu vaccine, measles and rubella, should not be used in these cases. Thomas Breuer, GSK Senior Vice president, Chief Medical Officer, Vaccines, tells ASSET about a new approach to protect babies against a dangerous infection such as SRV (syncytial respiratory virus), by immunising mothers during pregnancy with a vaccine which is currently under study at GSK.

Target: 
Citizens, Healthcare Professionals
Topic: 
Gender, Prevention, Vaccination
Tags: 
Vaccine, Vaccine safety, Pregnancy, Video

Pages

Subscribe to Vaccine safety

MMLAP and other EU Projects

AsiaFluCap
Health system analysis to support capacity development in response to the threat of pandemic influenza in Asia
BEWATER
Making society an active participant in water adaptation to global change
CASI
Public Participation in Developing a Common Framework for Assessment and Management of Sustainable Innovation
CIMULACT
Engaging all of Europe in shaping a desirable and sustainable future
DARWIN
Expect the unexpected and know how to respond
DRIVER
Driving innovation in crisis management for European resilience
ECOM
Effective communication in outbreak management: development of an evidence-based tool for Europe
EDEN
Solutions to improve CBRNe resilience
EPISOUTH
Network for Communicable Disease Control in Southern Europe and Mediterranean Countries
EPIWORK
Developing the framework for an epidemic forecast infrastructure
EUPHARE
Strengthening of the national surveillance system for communicable diseases
EUROHEP
Surveillance of vaccine preventable hepatitis
EuroMOMO
European monitoring of excess mortality for public health action
EURONHID
European network for highly infectious disease
EUVAC.NET
Dedicated surveillance network for surveillance and control of vaccine preventable diseases in the EU
FLUMODCONT
Modelling the spread of pandemic influenza and strategies for its containment and mitigation
FLURESP
Cost-effectiveness assessment of european influenza human pandemic alert and response strategies
GAP2
Bridging the gap between science, stakeholders and policy makers
HProImmune
Promotion of immunization for health professionals in Europe
INPROFOOD
Towards inclusive research programming for sustainable food innovations
JA-CHRODIS
Addressing chronic diseases and healthy ageing across the life cycle
M-Eco
Medical ecosystem – personalized event-based surveillance
MAPPING
Studying the many and varied economic, social, legal and ethical aspects of the recent developments on the Internet, and their consequences for the individual and society at large
MARINA
Get involved in the responsible marine research and innovation
PACITA
Knowledge-based policy-making on issues involving science, technology and innovation, mainly based upon the practices in Parliamentary Technology Assessment
PANDEM
Assessment of the current pandemic preparedness and response tools, systems and practice at national, EU and global level in priority areas
PE2020
Analysis of innovative public engagement tools and instruments for dynamic governance in the field of Science in Society
PERARES
Public Engagement with Research And Research Engagement with Society
PHEME
Computing Veracity – the Fourth Challenge of Big Data
PREPARE
Providing infrastructure, co-ordination and integration of existing clinical research networks on epidemics and pandemics
PROMOVAX
Promote vaccinations among migrant population in Europe
R&DIALOGUE
Creating mechanisms for effectively tackling the scientific and technology related challenges faced by society
RESPIRE
Improve the quality of indoor air, keeping it free from radon
SATORI
Improving respect of ethics principles and laws in research and innovation, in line with the evolution of technologies and societal concerns
SECURING CITIES AGAINST GLOBAL PANDEMICS
Investigating how cities in the West securitise against global pandemics
SEiSMiC
Creating a structured dialogue and mutual learning with citizens and urban actors by setting up National Networks in 10 countries across Europe
SIS CATALYST
Identifying how children can be change agents in the Science and Society relationship
SYN-ENERGENE
Establishing an open dialogue between stakeholders concerning synthetic biology’s potential benefits and risks
TELLME
Transparent communication in Epidemics: Learning Lessons from experience, delivering effective Messages, providing Evidence